These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26059720)

  • 1. Regulating against the dysregulation: new treatment options in autoinflammation.
    Kallinich T
    Semin Immunopathol; 2015 Jul; 37(4):429-37. PubMed ID: 26059720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoinflammatory Disorders: A Review and Update on Pathogenesis and Treatment.
    Havnaer A; Han G
    Am J Clin Dermatol; 2019 Aug; 20(4):539-564. PubMed ID: 30997665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the inflammasome in patients with autoinflammatory diseases.
    Hoffman HM; Broderick L
    J Allergy Clin Immunol; 2016 Jul; 138(1):3-14. PubMed ID: 27373321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to autoinflammatory syndromes and diseases.
    Abramovits W; Oquendo M
    Dermatol Clin; 2013 Jul; 31(3):363-85. PubMed ID: 23827242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoinflammatory disorders, pain, and neural regulation of inflammation.
    Chen MC; Meckfessel MH
    Dermatol Clin; 2013 Jul; 31(3):461-70. PubMed ID: 23827248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling inflammation: contemporary treatments for autoinflammatory diseases and syndromes.
    Sterba G; Sterba Y
    Dermatol Clin; 2013 Jul; 31(3):507-11. PubMed ID: 23827252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammasome and cytokine blocking strategies in autoinflammatory disorders.
    Moll M; Kuemmerle-Deschner JB
    Clin Immunol; 2013 Jun; 147(3):242-75. PubMed ID: 23697917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases.
    Clark JD; Flanagan ME; Telliez JB
    J Med Chem; 2014 Jun; 57(12):5023-38. PubMed ID: 24417533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Switching to biological agents in autoimmune and autoinflammatory disorders: current targets and therapy.
    Gasparyan AY
    Curr Med Chem; 2015; 22(16):1890-1. PubMed ID: 25693591
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologic drugs in autoinflammatory syndromes.
    Caorsi R; Federici S; Gattorno M
    Autoimmun Rev; 2012 Nov; 12(1):81-6. PubMed ID: 22884553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The body against self: autoinflammation and autoimmunity.
    Borella E; Palma L; Zen M; Bettio S; Nalotto L; Gatto M; Domeneghetti M; Laccarino L; Punzi L; Doria A
    Isr Med Assoc J; 2014 Oct; 16(10):608-10. PubMed ID: 25438443
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted Treatment of Diseases of Immune Dysregulation.
    Mohan S
    Rheum Dis Clin North Am; 2023 Nov; 49(4):913-929. PubMed ID: 37821203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update upon efficacy and safety of TNF-α inhibitors.
    Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
    Expert Opin Drug Saf; 2012 Jan; 11(1):1-5. PubMed ID: 22010813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoinflammatory conditions: when to suspect? How to treat?
    Grateau G; Duruöz MT
    Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):401-11. PubMed ID: 20534373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoinflammatory diseases in pediatrics.
    Hausmann JS; Dedeoglu F
    Dermatol Clin; 2013 Jul; 31(3):481-94. PubMed ID: 23827250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New biological drugs for the treatment of chronic inflammatory diseases].
    Skov L; Hegedüs L; Madsbad S; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2162. PubMed ID: 18572482
    [No Abstract]   [Full Text] [Related]  

  • 17. The beneficial effects of statins in autoimmune disease therapy.
    Marai I; Shoenfeld Y
    Drug News Perspect; 2007 Apr; 20(3):165-9. PubMed ID: 17520093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological response modifiers in the treatment of immunoinflammatory diseases].
    Skov L; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2120-6. PubMed ID: 18565292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spurs in the hunt for new immunomodulatory drug targets.
    Ward SG; O'Neill LA
    Curr Opin Pharmacol; 2012 Aug; 12(4):439-43. PubMed ID: 22770734
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives.
    Lopalco G; Cantarini L; Vitale A; Iannone F; Anelli MG; Andreozzi L; Lapadula G; Galeazzi M; Rigante D
    Mediators Inflamm; 2015; 2015():194864. PubMed ID: 25784780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.